Angiotensin receptor blockers and antiplatelet agents are associated with improved primary patency after arteriovenous hemodialysis access placement Rubie Sue Jackson, MD, MPH, Anton N. Sidawy, MD, MPH, Richard L. Amdur, PhD, Akhil Khetarpal, MS, Robyn A. Macsata, MD Journal of Vascular Surgery Volume 54, Issue 6, Pages 1706-1712 (December 2011) DOI: 10.1016/j.jvs.2011.06.028 Copyright © 2011 Terms and Conditions
Fig 1 Subject inclusion/exclusion. AV, Arteriovenous. Journal of Vascular Surgery 2011 54, 1706-1712DOI: (10.1016/j.jvs.2011.06.028) Copyright © 2011 Terms and Conditions
Fig 2 Autogenous (A) and prosthetic (B) arteriovenous (AV) access primary patency, in angiotensin receptor blocker (ARB) users and nonusers. Shaded areas indicate 95% confidence interval (CI). Journal of Vascular Surgery 2011 54, 1706-1712DOI: (10.1016/j.jvs.2011.06.028) Copyright © 2011 Terms and Conditions